As on February 18, 2021, Novavax Inc. (NASDAQ: NVAX) started slowly as it slid -3.17% to $265.29. During the day, the stock rose to $281.00 and sunk to $262.6001 before settling in for the price of $273.98 at the close. Taking a more long-term approach, NVAX posted a 52-week range of $6.77-$331.68.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -9.50%. Meanwhile, its Annual Earning per share during the time was 5.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 44.90%. This publicly-traded company’s shares outstanding now amounts to $67.26 million, simultaneously with a float of $62.92 million. The organization now has a market capitalization sitting at $17.38 billion. At the time of writing, stock’s 50-day Moving Average stood at $167.65, while the 200-day Moving Average is $113.88.
While finding the extent of efficiency of the company that is accounted for 165 employees. It has generated 113,103 per worker during the last fiscal year. Meanwhile, its income per employee was -804,206. The stock had 4.98 Receivables turnover and 0.10 Total Asset turnover. For the Profitability, stocks operating margin was -694.44 and Pretax Margin of -711.04.
Novavax Inc. (NVAX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Novavax Inc.’s current insider ownership accounts for 0.10%, in contrast to 51.70% institutional ownership. According to the most recent insider trade that took place on Feb 18, this organization’s President, R&D sold 2,434 shares at the rate of 269.57, making the entire transaction reach 656,134 in total value, affecting insider ownership by 2,811. Preceding that transaction, on Feb 16, Company’s President, R&D sold 5,712 for 282.71, making the whole transaction’s value amount to 1,614,812. This particular insider is now the holder of 2,811 in total.
Novavax Inc. (NVAX) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 9/29/2020, the company posted -$3.21 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at $1.73) by -$4.94. This company achieved a net margin of -711.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.93 per share during the current fiscal year.
Novavax Inc.’s EPS increase for this current 12-month fiscal period is 44.90% and is forecasted to reach 18.81 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by 0.00% through the next 5 years, which can be compared against the 5.60% growth it accomplished over the previous five years trading on the market.
Novavax Inc. (NASDAQ: NVAX) Trading Performance Indicators
Let’s observe the current performance indicators for Novavax Inc. (NVAX). It’s Quick Ratio in the last reported quarter now stands at 2.80. The Stock has managed to achieve an average true range (ATR) of 23.25. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 84.89. Similarly, its price to free cash flow for trailing twelve months is now 351.20.
In the same vein, NVAX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.22, a figure that is expected to reach -1.15 in the next quarter, and analysts are predicting that it will be 18.81 at the market close of one year from today.
Technical Analysis of Novavax Inc. (NVAX)
Through scrutinizing the latest numbers posted by the [Novavax Inc., NVAX], it can be observed that its last 5-days Average volume of 2.7 million was lower the volume of 5.25 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 23.22% While, its Average True Range was 25.48.
Raw Stochastic average of Novavax Inc. (NVAX) in the period of the previous 100 days is set at 73.97%, which indicates a major rise in contrast to 58.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 225.25% that was higher than 125.54% volatility it exhibited in the past 100-days period.